Objective: Determine the prevalence of erectile dysfunction in patients undergoing hemodialysis.
INTRODUCTION
Life expectancy of patients with chronic renal failure (CRF) increased during the last decades with the improvement of renal replacement techniques -dialysis and renal transplantation. However, new complications or aggravation of preexisting diseases do impair the quality of life of these men. Erectile dysfunction (ED) is frequently observed in patients undergoing hemodialysis (HD) program, with prevalence ranging between 41% and 98% (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . From 1997, with the development of the International Index of Erectile Function (IIEF) (13) , an instrument was created for uniform assessment of erectile dysfunc-tion, by standardizing the questions and classifying the answers into categories. This study has been developed to assess erectile dysfunction prevalence in patients with Chronic Renal Failure utilizing the IIEF.
MATERIALS AND METHODS
Seventy patients older than 18 years have been selected in two hemodialysis centers and from these 58 patients (83%) agreed to participate in the research and signed the Informed Consent. The patients answered the IIEF questionnaire including the six questions about health-related determinants of the erectile function (questions number 1 to 5 and question number 15). The total score ranges from 1 to 30, by being characterized as severe [ In the standard questionnaire applied sociodemographic data have been obtained (age, civil status and education level), presence of comorbidities (arterial hypertension and diabetes mellitus -DM) and time of hemodialysis.
Hematocrit, hemoglobin, calcium, phosphorus, potassium, pre-and post-dialysis urea and Kt/V values have been all obtained from the medical charts, as well as the cause of the CRF.
Patients presenting ED were questioned if they have already searched for medical care for this problem.
Descriptive analysis of sociodemographic, clinic and laboratory data of the patients has been performed. The Student t test was utilized to compare laboratory results between patients with and without ED. The chisquare (χ 2 ) test was utilized to compare the comorbidities and the characteristics of the population studied between the groups of patients with and without ED. The significance level considered was 5%.
RESULTS
The study included fifty-eight (58) patients with age ranging from 21 to 76 years (mean age of 50.2 ± 14.6 years). The proportion between patients younger and older than 50 years was, respectively, 53.5% and 46.5%. Patients undergone hemodialysis for a minimum period of one week and a maximum period of 102 months (mean of 30.4 ± 28.4 months). Patients' data can be found in Table- 1.
The prevalence of ED was 60.3% ( Figure-1 ). Progressive increase respecting the age was found. In patients younger than 50 years, the prevalence of ED was 31.4%, reaching 68.6% in those patients older than 50 years (p < 0.05).
No statistic association between sociodemographic variables and ED has been found.
Hypertensive patients prevailed in the study (94.8%) with respect to the diabetic patients (24.9%). However only the association between DM and ED was significant (Table-2) .
Time of dialysis was not a factor associated to the presence of ED in the population under study. 
COMMENTS
In our sample, the prevalence of ED was 60.3%. Taking into consideration the only severe category, the prevalence was 27.6%. Initial studies reported that ED in patients undergoing hemodialysis ranged between 41% and 93% (1-3). Since the methodology of such studies was not uniform, the comparison of the results found was not adequate. In studies in which the International Index of Erectile Function (IIEF) was utilized, the prevalence of ED ranged between 57.9% and 86.4% (4) (5) (6) (7) (8) (9) (10) (11) (12) , evidencing that such dysfunction is frequent in patients with CRF (Table-3 ). Severe ED affects from 28% to 45% of these patients.
It is found in literature that ED is age-related (6) (7) (8) 12, 14) . By stratifying the age of our patients below and above 50 yeas of age, we found, respectively, 31.4% and 68.6%, of ED prevalence.
The presence of hypertension found in our patients was 94.8%. However, this association was not significant. Several studies with chronic renal patients found in literature do confirm this finding (1-8). Feldman et al. (15) pointed out the occurrence of severe ED in 15% of hypertensive patients treated against 9.6% in the general population. The study does not indicate, however, if this association was originated from the hypertension or from the use of antihypertensive medication by considering that there is also an association between ED and the use of hypotensives. It can be argued that the high degree of vascular impairment (atherosclerosis) present in men with CRF undergoing hemodialysis is at least partially responsible for the erectile mechanism aggravation (15) .
With reference to the DM, there was a significant statistic association to the ED. This study indicated that only one amongst the fifteen patients did not have ED. In the patients evaluated by Cerqueira et al. (5), 99% of the diabetic patients presented ED. This association has been also found in other studies (4, 8, 10, 15) .
No statistic association of ED has been found with reference to civil status, education or ethnic groups. In the MMAS longitudinal study, Johannes et al. (14) reported that the risk of developing age-related ED was higher in men with lower education degree. In our group, Moreira et al. (16) found that the education was inversely correlated to ED. Study carried out in four North-American cities, including 1,680 men older than 40 years of age, demonstrated that ED was not related to ethnic groups (17) .
Time of dialysis was not also a factor associated to the presence of ED in the population under study, similar result was found by other authors (6) (7) (8) .
Kt/V, measure of the quantity of plasma cleared of urea (K x t) divided by the volume of urea distribution (V) is an index utilized to assess dialysis adequacy. Patients with erectile dysfunction presented statistically significant lower values for Kt/V (0.9) when compared to patients without erectile dysfunction (1.2). Some authors (18, 19) recommend one Kt/ V of 1.3 for providing adequate hemodialysis. Therefore, the indexes found in our study can indicate that a hemodialysis within acceptable standards may contribute to prevent ED. This relation has not been found in other studies (1,4,7) .
Miyata et al. (10) found in literature that higher values of hemoglobin were associated to severe ED. In our study, hematocrit and hemoglobin were both found to be higher in patients without ED, when compared with those with ED, but they show no statistic difference.
Amongst patients with ED, only three of them (8.6%) sought medical guidance. In the studies with chronic renal patients, the search for medical treatment ranged between 1% and 9.6% (7, 8) . It is found in literature that less than 10% of men seek medical care for ED (20) . Moreira et al. (21) found that the number of individuals with ED that sought medical help was of 42%. The lack of approach regarding sexuality is caused, mostly, by health professionals that are not used to question the topic. The majority of the men doctors (62.5%) and women doctors (71.5%) reported that they do not routinely investigate the sexual function of the male patients. In a routine consultation, only 11.1% and 8.7% of the men doctors and women doctors, respectively, reported they were used to always investigate the sexual function of male patients. Amongst the patients, 78% of them did not refer about having problems to discuss sexual issues with their physicians (21) .
CONCLUSIONS
The prevalence of ED in patients in hemodialysis program was 60.3%. However, only 8.6% of these patients search for medical help. Age, diabetes and hemodialysis characteristics are associated with higher incidence of ED. Physicians and other health professionals shall pay attention to the erection problems in this group of patients in order to provide directions for an adequate medical treatment.
